Roche reports inadvertent disclosure in lung cancer immunotherapy study Ruchika Sharma23 Aug 2023 2:30 PM ISTBasel: Roche announced today that it has been made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01...
Roche Gets CDSCO Nod To Study Anticancer FDC Drug Dr. Divya Colin25 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Personalised mRNA vaccine shows promise in delaying pancreatic ductal adenocarcinoma relapse Jacinthlyn Sylvia17 May 2023 8:00 PM ISTA new study published in Nature Journal shows that adjuvant autogene cevumeran, a personalized mRNA neoantigen vaccine, in combination with...
Atezolizumab may not lower recurrence risk after resection of renal carcinoma, show trial results Aditi17 Oct 2022 6:00 AM ISTUSA: The results of a multicentre, randomized, double-blind, phase 3 trial published in The Lancet have evaluated the role of Atezolizumab as...
Roche anti-cancer drug Atezolizumab gets CDSCO panel nod for Metastatic Triple Negative Breast Cancer Rahul Verma15 July 2022 4:53 PM ISTBased on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug Standard...
CDSCO panel nod to Roche anti cancer drug Atezolizumab for metastatic triple negative breast cancer Dr. Divya Colin14 July 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug...
Atezolizumab to help survival in bladder cancer patients with ctDNA positivity Isra Zaman7 July 2022 9:45 AM ISTResearchers treated a group of post-surgery bladder cancer patients with the immunotherapy drug atezolizumab and have found that patients whose...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Roche gets USFDA okay for cancer treatment Tecentriq Ruchika Sharma16 Oct 2021 4:30 PM ISTBasel: Roche has recently announced that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) as adjuvant treatment,...
Blood test could guide postoperative treatment in bladder cancer patients: Study Hina Zahid28 Jun 2021 9:00 AM ISTNovel findings demonstrate ctDNA as a marker for residual disease and response to atezolizumab. This may change the understanding of...
Roche Tecentriq Pivotal Phase III data shows hope for cancer patients Ruchika Sharma20 May 2021 11:00 AM ISTBasel: Roche today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq...
Rare case of autoimmune keratitis after Atezolizumab Treatment reported in NEJM Dr. Kamal Kant Kohli8 Oct 2020 10:30 AM ISTDr Joo Youn Oh at Seoul National University Hospital, Seoul, South Korea has reported a rare case of autoimmune keratitis after Atezolizumab...
